Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death

Gowtham A. Rao, Joshua R. Mann, Azza Shoaibi, Charles Lee Bennett, Georges Nahhas, S. Scott Sutton, Sony Jacob and Scott M. Strayer
The Annals of Family Medicine March 2014, 12 (2) 121-127; DOI: https://doi.org/10.1370/afm.1601
Gowtham A. Rao
1Department of Family and Preventive Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina
2William J.B. Dorn Veterans Affairs Medical Center, Columbia, South Carolina
3School of Public Health, Columbia, University of South Carolina, South Carolina
4South Carolina College of Pharmacy, Columbia, South Carolina
MD, PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gowtham.rao@va.gov
Joshua R. Mann
1Department of Family and Preventive Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina
3School of Public Health, Columbia, University of South Carolina, South Carolina
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azza Shoaibi
1Department of Family and Preventive Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina
2William J.B. Dorn Veterans Affairs Medical Center, Columbia, South Carolina
3School of Public Health, Columbia, University of South Carolina, South Carolina
4South Carolina College of Pharmacy, Columbia, South Carolina
BPharm, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Lee Bennett
2William J.B. Dorn Veterans Affairs Medical Center, Columbia, South Carolina
3School of Public Health, Columbia, University of South Carolina, South Carolina
4South Carolina College of Pharmacy, Columbia, South Carolina
MD, PhD, MPP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Georges Nahhas
3School of Public Health, Columbia, University of South Carolina, South Carolina
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Scott Sutton
2William J.B. Dorn Veterans Affairs Medical Center, Columbia, South Carolina
4South Carolina College of Pharmacy, Columbia, South Carolina
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sony Jacob
2William J.B. Dorn Veterans Affairs Medical Center, Columbia, South Carolina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott M. Strayer
1Department of Family and Preventive Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Published eLetters

If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

  • Riaks and benefits discussions require natural frequencies
    David L. Hahn
    Published on: 27 March 2014
  • Doctors: Watch Out for the Antibiotics-induced QT Prolongation
    Gan-Xin Yan
    Published on: 27 March 2014
  • Published on: (27 March 2014)
    Page navigation anchor for Riaks and benefits discussions require natural frequencies
    Riaks and benefits discussions require natural frequencies
    • David L. Hahn, Director

    Rao et al. add to the growing observational data that azithromycin and, to a somewhat greater extent, levofloxacin, are associated with tiny incremental risks of sudden death, plausibly due to cardiac arrythmias. The authors state "Risks and benefits of antibacterial therapies should be considered when making prescription decisions" but they fail to frame the risks in ways that are useful to patients (and their physicians...

    Show More

    Rao et al. add to the growing observational data that azithromycin and, to a somewhat greater extent, levofloxacin, are associated with tiny incremental risks of sudden death, plausibly due to cardiac arrythmias. The authors state "Risks and benefits of antibacterial therapies should be considered when making prescription decisions" but they fail to frame the risks in ways that are useful to patients (and their physicians) in making these informed choices. They should have stated that the number needed to harm (for death) was less than 1 in 13,000 for azithromycin, and less than 1 in 2500 for levofloxacin. They also should have pointed out that relative measures like hazard ratios and their confidence intervals are useful to decide whether differences are statistically significant but are not useful (actually quite the opposite) when making informed decisions.

    I also advocate that the editors of this (and every) primary care journal REQUIRE that authors PROMINENTLY present benefits and risks in terms, such as natural frequencies, NNT & NNH, that prescribers and their patients can use in shared decision making.

    Competing interests: ?? None declared

    Show Less
    Competing Interests: None declared.
  • Published on: (27 March 2014)
    Page navigation anchor for Doctors: Watch Out for the Antibiotics-induced QT Prolongation
    Doctors: Watch Out for the Antibiotics-induced QT Prolongation
    • Gan-Xin Yan, Doctor.
    • Other Contributors:

    It has been known that all macrolide antibiotics have a potential risk to cause QT prolongation and resultant torsade de pointes. Among macrolides, azithromycin, with minimal side effects, is considered to be usually better tolerated. In the present article, Rao and colleagues retrospectively investigated the data of 14 million people and defined among them 1.6 million who received the treatment of azithromysin, levoflo...

    Show More

    It has been known that all macrolide antibiotics have a potential risk to cause QT prolongation and resultant torsade de pointes. Among macrolides, azithromycin, with minimal side effects, is considered to be usually better tolerated. In the present article, Rao and colleagues retrospectively investigated the data of 14 million people and defined among them 1.6 million who received the treatment of azithromysin, levofloxacin or amoxicillin, and found that levofloxacin and azithromycin significantly increased not only the mortality but also cardiac arrhythmias when compared with amoxicillin. Azithromycin increased the risks on day 1 to 5, while the risk of levofloxacin could last as long as 10-days.

    The main mechanisms underlying the increased risks of arrhythmia and mortality of levofloxacin and azithromycin are their property to prolong the QT duration, and then consequently lead to bradycardia and atrioventricular block, and, through reverse use-dependence, to result in torsade de pointes[1]. Levofloxacin, with its significant effects of QT prolongation, is even regarded as a positive control for the Thorough QT Study of other antibiotic candidates[2]. Previous studies have shown that QT prolongation, regardless of its underlying causes, was associated with an increased mortality in the general population as well as in the people with coronary artery disease[3-4].

    Interestingly, azithromycin was not found to be associated with increased risks of death in a previous study by Svanstrom et al[5]. The conflict results may result from the difference in ages between the previous study and the current study. The mean age of the subjects in the study of Rao et al is 56.5 years, older than that (39.7 +-13.9yr) of the subjects in Svanstrom's study. The reasons underlying this unfavorable profile for older people are closely associated with their comparatively complicated clinical profile. On the one hand, older people are more likely to have concomitant diseases like ventricular hypertrophy that may reduce repolarization reserve and render the older people more sensitive to QT-prolonging antibiotics. On the other hand, older people have a reduced creatinine clearance and are more likely to take other drugs, some of which might have certain impact upon the metabolism and kinetics of the antibiotics. Both may significantly raise the concentrations of the antibiotics and therefore potentiate their electrophysiological effects, such as QT prolongation, which, in turn, set the stage for the occurrences of arrhythmias, especially torsade de pointes. So the suggestions in the use of these antibiotics in clinic are to choose, if possible, other alternative antibiotics, or to require, in the absence of alternatives, close monitoring from the start, involving assessment of risk markers before the start of therapy, especially when used in combination with other QT-prolonging drugs.

    References
    1. Jia S, Lian J, Guo D, Xue X, Patel C, Yang L, et al. Modulation of the Late Sodium Current by ATX-II and Ranolazine Affects the Reverse Use-Dependence and Proarrhythmic Liability of IKr Blockade. British Journal of Pharmacology. 2011; 164(2): 308-316.
    2. Taubel J1, Naseem A, Harada T, et al. Levofloxacin Can Be Used Effectively as a Positive Control in Thorough QT/QTc Studies in Healthy Volunteers. British Journal of Clinical Pharmacology, 2010, 69(4): 391-400.
    3. Straus SM, Sturkenboom MC, Bleumink GS, Dieleman JP, van der Lei J, de Graeff PA, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005; 26(19):2007-2012.
    4. Chugh SS, Reinier K, Singh T,Uy-Evanado A, Socoteanu C, Peters D, et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation. 2009;119(5):663-670.
    5. Svanstrom H, Pasternak B, Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl J Med. 2013;368(18):1704-1712.

    Competing interests: None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 12 (2)
The Annals of Family Medicine: 12 (2)
Vol. 12, Issue 2
March/April 2014
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Gowtham A. Rao, Joshua R. Mann, Azza Shoaibi, Charles Lee Bennett, Georges Nahhas, S. Scott Sutton, Sony Jacob, Scott M. Strayer
The Annals of Family Medicine Mar 2014, 12 (2) 121-127; DOI: 10.1370/afm.1601

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death
Gowtham A. Rao, Joshua R. Mann, Azza Shoaibi, Charles Lee Bennett, Georges Nahhas, S. Scott Sutton, Sony Jacob, Scott M. Strayer
The Annals of Family Medicine Mar 2014, 12 (2) 121-127; DOI: 10.1370/afm.1601
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Antibiotic utilisation and the impact of antimicrobial resistance action plan on prescribing among older adults in New Zealand between 2005 and 2019
  • Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
  • BET 1: What is the incidence of cardiac arrhythmia in adult patients with acute infection prescribed fluoroquinolones?
  • Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea
  • Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung Diseases
  • Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
  • Estimated Cardiac Risk Associated With Macrolides and Fluoroquinolones Decreases Substantially When Adjusting for Patient Characteristics and Comorbidities
  • Does macrolide use confer risk of out-of-hospital cardiac arrest compared with penicillin V? A Danish national case-crossover and case-time-control study
  • Indias antibiotic combinations thwart efforts to curb drug resistance, say researchers
  • Use of azithromycin and risk of ventricular arrhythmia
  • Macrolide antibiotics and the risk of ventricular arrhythmia in older adults
  • Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes
  • Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain
  • In This Issue: Building Blocks for Improving Practice
  • Google Scholar

More in this TOC Section

  • Teamwork Among Primary Care Staff to Achieve Regular Follow-Up of Chronic Patients
  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
  • Convenience or Continuity: When Are Patients Willing to Wait to See Their Own Doctor?
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Acute illness
  • Methods:
    • Quantitative methods

Keywords

  • azithromycin
  • levofloxacin
  • amoxicillin
  • arrhythmia
  • cause of death

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine